Highly crystalline cross-linked oxidation-resistant polyethylene

US9168683B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9168683-B2
Application numberUS-201313826636-A
CountryUS
Kind codeB2
Filing dateMar 14, 2013
Priority dateFeb 3, 2004
Publication dateOct 27, 2015
Grant dateOct 27, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to methods for making highly crystalline cross-linked polymeric material, for example, highly crystalline cross-linked ultra-high molecular weight polyethylene (UHMWPE). The invention also provides methods of making antioxidant-doped highly crystalline cross-linked polymeric material using high pressure and high temperature crystallization processes, medical implants made thereof, and materials used therein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A medical implant comprising an oxidation resistant, cross-linked polymeric blend made by a process comprising the steps of: a) mixing a polymeric material with an antioxidant to form a polymeric blend, wherein the mixing is in the absence of a supercritical fluid, and wherein the polymeric material is polymeric resin powder, polymeric flakes, polymeric particles, or a mixture thereof; b) consolidating the polymeric blend; c) irradiating the polymeric blend by ionizing radiation at an elevated temperature that is above room temperature and below the peak melting point of the polymeric blend, thereby forming a cross-linked polymeric blend; d) mechanically deforming the cross-linked polymeric blend at a temperature below its melting point, thereby forming a mechanically deformed cross-linked polymeric blend; e) annealing the mechanically deformed cross-linked polymeric blend, thereby forming an oxidation resistant cross-linked polymeric blend; and f) machining the oxidation resistant cross-linked polymeric blend, thereby forming the medical implant. 2. The medical implant of claim 1 , wherein polymeric material is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or a mixture thereof. 3. The medical implant of claim 1 , wherein the polymeric material is compression molded to another piece or a medical implant prior to heating the polymeric material, thereby forming an interface or an interlocked hybrid material. 4. The medical implant of claim 1 is packaged and sterilized by ionizing radiation or gas sterilization, thereby forming a sterile medical implant. 5. The medical implant of claim 1 , wherein the antioxidant is an α-tocopherol. 6. The medical implant of claim 1 comprises medical devices selected from the group consisting of acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint component, bipolar hip replacements, tibial knee insert, tibial knee inserts with reinforcing metallic and polyethylene posts, intervertebral discs, sutures, tendons, heart valves, stents, and vascular grafts. 7. The medical implant of claim 1 , wherein the mechanically deformed cross-linked polymeric blend is annealed at a temperature that is above or below the melting point of the polymeric material. 8. The medical implant of claim 1 , wherein the annealing is carried out in air for at least for one minute to about 5 hours or more at about 130° C. 9. A method of making a medical implant comprising an oxidation resistant cross-linked blend of polymeric material, wherein the oxidation resistant cross-linked blend of polymeric material is made by a process comprising the steps of: a) blending the polymeric material with an antioxidant, wherein the blending is in the absence of a supercritical fluid, and wherein the polymeric material is polymeric resin powder, polymeric flakes, polymeric particles, or a mixture thereof; b) consolidating the blend; c) irradiating the blend of polymeric material with ionizing radiation at an elevated temperature that is above room temperature and below the melting point of the blend of polymeric material, thereby forming a cross-linked blend of polymeric material; and d) machining the cross-linked blend of polymeric material, thereby forming the medical implant. 10. The method of claim 9 , wherein the antioxidant is an α-tocopherol. 11. The method of claim 9 , wherein the antioxidant concentration is about 0.01 wt/wt %, 0.02 wt/wt %, 0.05 wt/wt %, 0.1 wt/wt %, 0.2 wt/wt %, 0.5 wt/wt %, or 1.0 wt/wt %. 12. The method of claim 9 , wherein polymeric material is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or a mixture thereof. 13. The method of claim 9 , wherein the polymeric material is irradiated at a temperature between about room temperature and less than about 155° C. 14. The method of claim 9 , wherein the blend of polymeric material is irradiated at a temperature of about 90° C., about 100° C., about 110° C., about 120° C., about 130° C., or about 135° C. 15. The method of claim 9 , wherein the radiation dose is between about 25 and about 1000 kGy. 16. The method according to claim 9 , wherein the implant comprises medical devices selected from the group consisting of acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint component, bipolar hip replacements, tibial knee insert, tibial knee inserts with reinforcing metallic and polyethylene posts, intervertebral discs, sutures, tendons, heart valves, stents, and vascular grafts. 17. The method of claim 9 , wherein the medical implant is packaged and sterilized by ionizing radiation or gas sterilization, thereby forming a sterile medical implant. 18. A method of making a medical implant comprising an oxidation resistant cross-linked and interlocked hybrid material, wherein the oxidation resistant cross-linked and interlocked hybrid material is made by a process comprising the steps of: a) blending the polymeric material with an antioxidant, thereby forming a polymeric blend, wherein the blending is in the absence of a supercritical fluid, and wherein the polymeric material is polymeric resin powder, polymeric flakes, polymeric particles, or a mixture thereof; b) compression molding the polymeric blend to the counterface of a second material, thereby forming an interlocked hybrid material having an interface between the polymeric blend and the second material; c) irradiating the interlocked hybrid material with ionizing radiation at an elevated temperature that is above room temperature and below the melting point of the polymeric blend, thereby forming a cross-linked and interlocked hybrid material; and d) machining the cross-linked interlocked hybrid material, thereby forming the medical implant. 19. The method of claim 18 , wherein the second material is porous, metallic, a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell. 20. The method of claim 18 , wherein the polymeric material is a polyolefin, a polypropylene, a polyamide, a polyether ketone, or a mixture thereof. 21. The method of claim 18 , wherein polymeric material is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or a mixture thereof. 22. The method of claim 18 , wherein the interlocked hybrid material is irradiated at a temperature between about room temperature and less than about 155° C. 23. The method of claim 18 , wherein the interlocked hybrid material is irradiated at a temperature of about 90° C., about 100° C., about 110° C., about 120° C., about 130° C., or about 135° C. 24. The method of claim 18 , wherein the radiation dose is between about 25 and about 1000 kGy. 25. The method of claim 18 comprises medical devices selected from the group consisting of acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint c

Assignees

Inventors

Classifications

  • Joints · CPC title

  • characterised by the choice of material · CPC title

  • Treatment by wave energy or particle radiation · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

  • Thermal after-treatment {(B29C71/0063 and B29C71/0072 take precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9168683B2 cover?
The present invention relates to methods for making highly crystalline cross-linked polymeric material, for example, highly crystalline cross-linked ultra-high molecular weight polyethylene (UHMWPE). The invention also provides methods of making antioxidant-doped highly crystalline cross-linked polymeric material using high pressure and high temperature crystallization processes, medical implan…
Who is the assignee on this patent?
Gen Hospital Corp
What technology area does this patent fall under?
Primary CPC classification B29C35/08. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).